Litcius/Paper detail

Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody

Nobuhiko Kanaya, Shinji Kuroda, Yoshihiko Kakiuchi, Kento Kumon, Tomoko Tsumura, Masashi Hashimoto, Toshiaki Morihiro, Tetsushi Kubota, Katsuyuki Aoyama, Satoru Kikuchi, Masahiko Nishizaki, Shunsuke Kagawa, Hiroshi Tazawa, Hiroyuki Mizuguchi, Yasuo Urata, Toshiyoshi Fujiwara

2020Molecular Therapy78 citationsDOIOpen Access PDF

Topics & Concepts

Immunogenic cell deathOncolytic virusOncolytic adenovirusTelomeraseCancer researchImmune systemFOXP3MedicineAntibodyCD8Immune checkpointImmunotherapyImmunologyBiologyGeneBiochemistryVirus-based gene therapy researchCancer Research and TreatmentsCAR-T cell therapy research
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody | Litcius